Rescuing COX-2 inhibitors from the waste bin

[1] Albini A, 2001, CANCER RES, V61, P8171

[2] COX-2: A molecular target for colorectal cancer prevention [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2840 - 2855

[3] Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy [J]. SEMINARS IN ONCOLOGY, 2004, 31 (02) : 2 - 11

[4] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J]. LANCET, 2005, 365 (9458) : 475 - 481

[5] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis [J]. LANCET, 2004, 364 (9450) : 2021 - 2029

[6] Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427

[7] 2005, DRUG THER B, V43, P1

[1] Albini A, 2001, CANCER RES, V61, P8171

[2] COX-2: A molecular target for colorectal cancer prevention [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2840 - 2855

[3] Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy [J]. SEMINARS IN ONCOLOGY, 2004, 31 (02) : 2 - 11

[4] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J]. LANCET, 2005, 365 (9458) : 475 - 481

[5] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis [J]. LANCET, 2004, 364 (9450) : 2021 - 2029

[6] Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427

[7] 2005, DRUG THER B, V43, P1